Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen

Eveline Broers; Jack Beck; Marij Dinkelman-Smit; Gert Dohle; Henk Elzevier; Kathleen D’Hauwers; Wim Levens; Boaz Meijer; Garry Pigot; Brechje Ronkes; Janneke van Uhm; Jeannette Verkerk-Geelhoed; Afina Glas

doi:https://doi.org/10.1007/s13629-022-00349-y

Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen

Translated title of the contribution: First result of patient outcome after five years of regionalisation in implanting penile prosthesis for therapy resistent erectile dysfunction in The Netherlands

Eveline Broers, Jack Beck, Marij Dinkelman-Smit, Gert Dohle, Henk Elzevier, Kathleen D’Hauwers, Wim Levens, Boaz Meijer, Garry Pigot, Brechje Ronkes, Janneke van Uhm, Jeannette Verkerk-Geelhoed, Afina Glas

Research output: Contribution to journal › Article › Professional

Abstract

Since 2016 the penile prosthesis is reimbursed when patients meet indication and quality criteria which are stated in the NVU statement. The Dutch implanters have bundled the data of their first five years of implanting penile prosthesis. Patient satisfaction is higher than previously with 82% and prosthesis use was reported in 86% of the patients. These numbers are higher in the primary group compared to the group with reimplantations. The risk of getting a serious complication is 5.8 and 7.5% respectively. Introducing validated PROMS and intensifying the collaboration with the seksuologists will optimize patient satisfaction and complication risk. Furthermore an optimalisation of national implantation volumes will be necessary.

Translated title of the contribution	First result of patient outcome after five years of regionalisation in implanting penile prosthesis for therapy resistent erectile dysfunction in The Netherlands
Original language	Dutch
Pages (from-to)	55-59
Number of pages	5
Journal	Tijdschrift voor Urologie
Volume	12
Issue number	2-3
Early online date	2022
DOIs	https://doi.org/10.1007/s13629-022-00349-y
Publication status	Published - Mar 2022

Keywords

inflatable penile prosthesis
malleable penile prosthesis
patient satisfaction

Access to Document

https://doi.org/10.1007/s13629-022-00349-y

Cite this

Broers, E., Beck, J., Dinkelman-Smit, M., Dohle, G., Elzevier, H., D’Hauwers, K., Levens, W., Meijer, B., Pigot, G., Ronkes, B., van Uhm, J., Verkerk-Geelhoed, J., & Glas, A. (2022). Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen. Tijdschrift voor Urologie, 12(2-3), 55-59. https://doi.org/10.1007/s13629-022-00349-y

@article{25822147f51c42cf84accfea4811d81f,

title = "Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen",

abstract = "Since 2016 the penile prosthesis is reimbursed when patients meet indication and quality criteria which are stated in the NVU statement. The Dutch implanters have bundled the data of their first five years of implanting penile prosthesis. Patient satisfaction is higher than previously with 82% and prosthesis use was reported in 86% of the patients. These numbers are higher in the primary group compared to the group with reimplantations. The risk of getting a serious complication is 5.8 and 7.5% respectively. Introducing validated PROMS and intensifying the collaboration with the seksuologists will optimize patient satisfaction and complication risk. Furthermore an optimalisation of national implantation volumes will be necessary.",

keywords = "inflatable penile prosthesis, malleable penile prosthesis, patient satisfaction",

author = "Eveline Broers and Jack Beck and Marij Dinkelman-Smit and Gert Dohle and Henk Elzevier and Kathleen D{\textquoteright}Hauwers and Wim Levens and Boaz Meijer and Garry Pigot and Brechje Ronkes and {van Uhm}, Janneke and Jeannette Verkerk-Geelhoed and Afina Glas",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = mar,

doi = "https://doi.org/10.1007/s13629-022-00349-y",

language = "Dutch",

volume = "12",

pages = "55--59",

journal = "Tijdschrift voor Urologie",

issn = "2211-3037",

publisher = "Springer Science + Business Media",

number = "2-3",

}

Broers, E, Beck, J, Dinkelman-Smit, M, Dohle, G, Elzevier, H, D’Hauwers, K, Levens, W, Meijer, B, Pigot, G , Ronkes, B, van Uhm, J, Verkerk-Geelhoed, J & Glas, A 2022, 'Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen', Tijdschrift voor Urologie, vol. 12, no. 2-3, pp. 55-59. https://doi.org/10.1007/s13629-022-00349-y

TY - JOUR

T1 - Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen

AU - Broers, Eveline

AU - Beck, Jack

AU - Dinkelman-Smit, Marij

AU - Dohle, Gert

AU - Elzevier, Henk

AU - D’Hauwers, Kathleen

AU - Levens, Wim

AU - Meijer, Boaz

AU - Pigot, Garry

AU - Ronkes, Brechje

AU - van Uhm, Janneke

AU - Verkerk-Geelhoed, Jeannette

AU - Glas, Afina

PY - 2022/3

Y1 - 2022/3

N2 - Since 2016 the penile prosthesis is reimbursed when patients meet indication and quality criteria which are stated in the NVU statement. The Dutch implanters have bundled the data of their first five years of implanting penile prosthesis. Patient satisfaction is higher than previously with 82% and prosthesis use was reported in 86% of the patients. These numbers are higher in the primary group compared to the group with reimplantations. The risk of getting a serious complication is 5.8 and 7.5% respectively. Introducing validated PROMS and intensifying the collaboration with the seksuologists will optimize patient satisfaction and complication risk. Furthermore an optimalisation of national implantation volumes will be necessary.

AB - Since 2016 the penile prosthesis is reimbursed when patients meet indication and quality criteria which are stated in the NVU statement. The Dutch implanters have bundled the data of their first five years of implanting penile prosthesis. Patient satisfaction is higher than previously with 82% and prosthesis use was reported in 86% of the patients. These numbers are higher in the primary group compared to the group with reimplantations. The risk of getting a serious complication is 5.8 and 7.5% respectively. Introducing validated PROMS and intensifying the collaboration with the seksuologists will optimize patient satisfaction and complication risk. Furthermore an optimalisation of national implantation volumes will be necessary.

KW - inflatable penile prosthesis

KW - malleable penile prosthesis

KW - patient satisfaction

UR - http://www.scopus.com/inward/record.url?scp=85124971487&partnerID=8YFLogxK

U2 - https://doi.org/10.1007/s13629-022-00349-y

DO - https://doi.org/10.1007/s13629-022-00349-y

M3 - Article

SN - 2211-3037

VL - 12

SP - 55

EP - 59

JO - Tijdschrift voor Urologie

JF - Tijdschrift voor Urologie

IS - 2-3

ER -

Vijf jaar regionalisatie van de behandeling erectieprothese bij therapieresistente erectiele disfunctie in Nederland, de eerste uitkomsten en ervaringen

Abstract

Keywords

Access to Document

Other files and links

Cite this